This manuscript synthesizes findings from a multidisciplinary panel following the RAND/UCLA Appropriateness Method to guide standardization of urinary catheter use after transurethral prostate surgery.
Ted A. Skolarus, MD, MPH
Advertisement
Articles by Ted A. Skolarus, MD, MPH
Healthcare integration was associated with small declines in treatment, but no change in overtreatment of prostate cancer. Integrated care delivery alone may be insufficient to curtail overtreatment.
Even in a fully integrated healthcare system, only 28% of cancer quality measures could be validated by using electronically available data.
Advertisement
Latest Updated Articles
- Validating Electronic Cancer Quality Measures at Veterans Health Administration
Published: December 11th 2014 | Updated:
- Implications of Evolving Delivery System Reforms for Prostate Cancer Care
Published: September 20th 2016 | Updated:
- Catheter Management After Benign Transurethral Prostate Surgery: RAND/UCLA Appropriateness Criteria
Published: December 5th 2019 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis
2
Pulling Back Funding for Research Could Leave HIV Treatment in Worse State: Patrick Sullivan, DVM, PhD
3
Value-Based Care Interventions and Management of CKD Progression
4
FDA Approves Cemiplimab as First, Only Adjuvant Immunotherapy for High-Risk CSCC
5
